Landscape Capital Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Landscape Capital Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,463	Closed	-$307K	–	965
2022 Q4	$307K	Hold	30,463	–	–	0.05%	383
2022 Q3	$302K	Buy	30,463 +400	+1%	+$3.96K	0.04%	453
2022 Q2	$293K	Hold	30,063	–	–	0.04%	440
2022 Q1	$296K	Buy	30,063 +1	+0%	+$10	0.04%	427
2021 Q4	$298K	Hold	30,062	–	–	0.04%	363
2021 Q3	$298K	Hold	30,062	–	–	0.04%	367
2021 Q2	$300K	Buy	30,062 +19,900	+196%	+$199K	0.04%	353
2021 Q1	$102K	Buy	+10,162	New	+$102K	0.02%	404

Landscape Capital Management's EBACU Position: Q1 2023 in Review

Landscape Capital Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2023, closing a stake of 30,463 shares — an estimated $307K sold.

Landscape Capital Management first reported a position in EBACU in Q1 2021 and held it in 8 quarters. The position peaked at $307K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACU as of Q1 2023.

Landscape Capital Management reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
Landscape Capital Management sold 30,463 European Biotech Acquisition Corp. Units shares in Q1 2023, an estimated $307K.
Landscape Capital Management first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 8 quarters.
Landscape Capital Management's European Biotech Acquisition Corp. Units position peaked at $307K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.